AAV-TNALP-D10 shows potential as one-time-dose treatment in murine model of hypophosphatasia Nov. 16, 2021
Verve announces preclinical data on GalNAc-LNP technology to deliver ANGPTL3 base editor in NHPs Nov. 9, 2021
RSS